Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 1,416,560 shares changed hands during mid-day trading, an increase of 301% from the previous session's volume of 353,665 shares.The stock last traded at $15.71 and had previously closed at $15.76.
Analysts Set New Price Targets
Several research analysts recently weighed in on the stock. Sanford C. Bernstein upgraded shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research report on Thursday, June 5th. Royal Bank Of Canada reissued an "outperform" rating on shares of Reckitt Benckiser Group in a research note on Friday, July 25th. Four analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy".
Get Our Latest Stock Report on Reckitt Benckiser Group
Reckitt Benckiser Group Trading Down 0.2%
The company has a quick ratio of 0.37, a current ratio of 0.56 and a debt-to-equity ratio of 1.01. The business's 50 day simple moving average is $14.60 and its 200 day simple moving average is $13.77.
Reckitt Benckiser Group Cuts Dividend
The firm also recently declared a dividend, which will be paid on Thursday, September 25th. Shareholders of record on Monday, August 11th will be issued a $0.2106 dividend. This represents a dividend yield of 341.0%. The ex-dividend date of this dividend is Friday, August 8th.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.